Literature DB >> 6465906

Erythema chronicum migrans of Lyme disease.

B W Berger.   

Abstract

Erythema chronicum migrans (ECM) is the distinctive cutaneous lesion of the multisystem tick-borne spirochetosis, Lyme disease. Its clinical and histologic pictures are variable. Of the 51 patients with ECM of Lyme disease, 38 patients (75%) had single lesions, 13 patients (25%) had multiple lesions, and 32 patients (62%) had extracutaneous signs and symptoms. Only 15 patients (29%) had symptoms referable to ECM. Extracutaneous signs and symptoms were absent in 12 (80%) of the 15 patients. These patients had uneventful recoveries following treatment with systemic antibiotics. Thirty-four skin biopsy specimens were obtained from the ECM lesions of 30 patients. With Warthin-Starry silver stain, the Ixodes dammini spirochete was found in 14 specimens (41%) taken from 12 (40%) of the 30 patients. Two of the Ixodes dammini spirochete-positive specimens were obtained from secondary ECM lesions. Careful clinical and histologic examination of skin lesions suggestive of ECM of Lyme disease will expedite its early diagnosis and treatment.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6465906

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  13 in total

Review 1.  Lyme disease.

Authors:  D W Rahn; S E Malawista
Journal:  West J Med       Date:  1991-06

2.  Increased incidence of Lyme borreliosis in southern Sweden following mild winters and during warm, humid summers.

Authors:  L Bennet; A Halling; J Berglund
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-07       Impact factor: 3.267

Review 3.  A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease.

Authors:  Paul M Lantos; Paul G Auwaerter; Gary P Wormser
Journal:  Clin Infect Dis       Date:  2013-12-12       Impact factor: 9.079

4.  Isogenic serotypes of Borrelia turicatae show different localization in the brain and skin of mice.

Authors:  D Cadavid; A R Pachner; L Estanislao; R Patalapati; A G Barbour
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Clinical appearance of erythema migrans caused by Borrelia afzelii and Borrelia garinii--effect of the patient's sex.

Authors:  Louise Bennet; Carl-Johan Fraenkel; Ulf Garpmo; Anders Halling; Mikael Ingman; Katharina Ornstein; Louise Stjernberg; Johan Berglund
Journal:  Wien Klin Wochenschr       Date:  2006-09       Impact factor: 1.704

6.  Overview of the clinical manifestations of Borrelia burgdorferi infection.

Authors:  R J Dattwyler; B J Luft
Journal:  Can J Infect Dis       Date:  1991

7.  Effects of environmental pH on membrane proteins in Borrelia burgdorferi.

Authors:  J A Carroll; C F Garon; T G Schwan
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

8.  Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin.

Authors:  B W Berger; R C Johnson; C Kodner; L Coleman
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

9.  The 93-kilodalton protein of Borrelia burgdorferi: an immunodominant protoplasmic cylinder antigen.

Authors:  B J Luft; S Mudri; W Jiang; R J Dattwyler; P D Gorevic; T Fischer; P Munoz; J J Dunn; W H Schubach
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

10.  Reinfection in erythema migrans disease.

Authors:  K Weber; G Schierz; B Wilske; U Neubert; H E Krampitz; A G Barbour; W Burgdorfer
Journal:  Infection       Date:  1986 Jan-Feb       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.